002923 润都股份
已收盘 08-21 15:00:00
资讯
新帖
简况
原料药与制剂协同放量,润都股份中报营收净利双增,一体化产业链优势加速兑现
证券之星 · 08-21 13:09
原料药与制剂协同放量,润都股份中报营收净利双增,一体化产业链优势加速兑现
图解润都股份中报:第二季度单季净利润同比增长166.07%
证券之星 · 08-21 01:45
图解润都股份中报:第二季度单季净利润同比增长166.07%
润都股份(002923)披露2026年半年度报告,8月20日股价上涨2.8%
证券之星 · 08-20 22:33
润都股份(002923)披露2026年半年度报告,8月20日股价上涨2.8%
股市必读:润都股份(002923)股东户数2.29万户,较上期增加9.49%
证券之星 · 08-14
股市必读:润都股份(002923)股东户数2.29万户,较上期增加9.49%
润都股份:截至2026年08月10日,公司总户数为22,860户
证券之星 · 08-13
润都股份:截至2026年08月10日,公司总户数为22,860户
8月5日润都股份发生5笔大宗交易 成交金额1462.92万元
证券之星 · 08-05
8月5日润都股份发生5笔大宗交易 成交金额1462.92万元
润都股份(002923)7月31日股东户数2.09万户,较上期减少9.89%
证券之星 · 08-04
润都股份(002923)7月31日股东户数2.09万户,较上期减少9.89%
润都股份:截至2026年07月31日,公司总户数为20,879户
证券之星 · 08-04
润都股份:截至2026年07月31日,公司总户数为20,879户
股市必读:7月28日润都股份发生2笔大宗交易 成交金额966万元
证券之星 · 07-29
股市必读:7月28日润都股份发生2笔大宗交易 成交金额966万元
润都股份(002923)7月20日股东户数2.32万户,较上期增加13.04%
证券之星 · 07-27
润都股份(002923)7月20日股东户数2.32万户,较上期增加13.04%
润都股份:截至2026年07月20日,公司总户数为23,171户
证券之星 · 07-27
润都股份:截至2026年07月20日,公司总户数为23,171户
润都股份(002923.SZ):硝酸异山梨酯注射液获得药品注册证书
智通财经 · 07-23
润都股份(002923.SZ):硝酸异山梨酯注射液获得药品注册证书
润都股份(002923)披露获得碳酸镧化学原料药上市申请批准通知书,7月21日股价下跌1.51%
证券之星 · 07-21
润都股份(002923)披露获得碳酸镧化学原料药上市申请批准通知书,7月21日股价下跌1.51%
润都股份(002923.SZ)获得碳酸镧化学原料药上市申请批准
智通财经 · 07-21
润都股份(002923.SZ)获得碳酸镧化学原料药上市申请批准
股市必读:润都股份(002923)股东户数1.86万户,较上期减少3.46%
证券之星 · 07-17
股市必读:润都股份(002923)股东户数1.86万户,较上期减少3.46%
润都股份:公司二季度业绩增长的主要原因为销售量增加及产能提升
证券之星 · 07-16
润都股份:公司二季度业绩增长的主要原因为销售量增加及产能提升
润都股份:截至2026年06月30日,公司总户数为18,568户
证券之星 · 07-16
润都股份:截至2026年06月30日,公司总户数为18,568户
润都股份(002923)披露盐酸去甲乌药碱注射液入选广东省创新药械产品目录(第三批),7月14日股价下跌2.13%
证券之星 · 07-14
润都股份(002923)披露盐酸去甲乌药碱注射液入选广东省创新药械产品目录(第三批),7月14日股价下跌2.13%
润都股份(002923)披露2026年半年度业绩预告,XX月XX日股价上涨5.72%
证券之星 · 07-13
润都股份(002923)披露2026年半年度业绩预告,XX月XX日股价上涨5.72%
润都股份预计上半年净利同比增长196.7%至216.04%
北京商报 · 07-12
润都股份预计上半年净利同比增长196.7%至216.04%
加载更多
公司概况
公司名称:
珠海润都制药股份有限公司
所属行业:
医药制造业
上市日期:
2018-01-05
主营业务:
珠海润都制药股份有限公司的主营业务是化学药制剂、化学原料药、中间体的研发、生产和销售。公司的主要产品是化学药制剂、化学原料药、中间体。公司是国家高新技术企业,国家绿色工厂、国家知识产权优势企业,研发中心先后被认定为国家级博士后科研工作站、国家企业技术中心、广东省企业技术中心、广东省缓控释微丸胶囊制剂工程研究中心,承担了国家重大新药创制专项、国家火炬计划、国家高新技术产业化项目等科研课题。
发行价格:
17.01
{"stockData":{"symbol":"002923","market":"SZ","secType":"STK","nameCN":"润都股份","latestPrice":11.28,"timestamp":1787295816000,"preClose":11.76,"halted":0,"volume":12925180,"delay":0,"changeRate":-0.0408,"floatShares":258000000,"shares":335000000,"eps":0.0403,"marketStatus":"已收盘","change":-0.48,"latestTime":"08-21 15:00:00","open":11.93,"high":11.94,"low":11.01,"amount":146000000,"amplitude":0.0791,"askPrice":11.28,"askSize":55,"bidPrice":11.25,"bidSize":108,"shortable":0,"etf":0,"ttmEps":0.0403,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1787535000000},"marketStatusCode":5,"adr":0,"adjPreClose":11.76,"symbolType":"stock","openAndCloseTimeList":[[1787275800000,1787283000000],[1787288400000,1787295600000]],"highLimit":12.94,"lowLimit":10.58,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":334893286,"isCdr":false,"pbRate":3.65,"roa":"--","peRate":279.900744,"roe":"3.85%","epsLYR":-0.19,"committee":0.46677,"marketValue":3778000000,"turnoverRate":0.0501,"status":1,"floatMarketCap":2911000000},"requestUrl":"/m/hq/s/002923","defaultTab":"news","newsList":[{"id":"2661254479","title":"原料药与制剂协同放量,润都股份中报营收净利双增,一体化产业链优势加速兑现","url":"https://stock-news.laohu8.com/highlight/detail?id=2661254479","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661254479?lang=zh_cn&edition=full","pubTime":"2026-08-21 13:09","pubTimestamp":1787288952,"startTime":"0","endTime":"0","summary":"证券之星注意到,这一业绩系统性修复背后,是润都股份一体化全产业链优势进入兑现期的具体体现。报告期内,原料药中间体营收同比大增近五成,制剂业务稳健增长,双主业协同驱动收入快速扩张;同时,子公司润都荆门产能利用率提升摊薄单位成本,推动毛利率明显回升。从财务质量来看,润都股份经营现金流大幅回暖,今年上半年较去年同期增长669.59%至7271.34万元,反映产品销售回款情况改善。仿制药方面,润都股份同样成果丰硕。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/SS2026082100020394.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002923"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661239120","title":"图解润都股份中报:第二季度单季净利润同比增长166.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2661239120","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661239120?lang=zh_cn&edition=full","pubTime":"2026-08-21 01:45","pubTimestamp":1787247922,"startTime":"0","endTime":"0","summary":"证券之星消息,润都股份2026年中报显示,上半年度公司主营收入7.09亿元,同比上升29.34%;归母净利润4075.1万元,同比上升212.59%;扣非净利润3311.81万元,同比上升173.85%;其中2026年第二季度,公司单季度主营收入3.6亿元,同比上升22.78%;单季度归母净利润2514.72万元,同比上升166.07%;单季度扣非净利润2249.13万元,同比上升152.86%;负债率46.71%,投资收益18.56万元,财务费用902.12万元,毛利率43.87%。财报数据概要请见下图:本文数据来源于润都股份2026年中报,仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082100001316.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002923"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660381942","title":"润都股份(002923)披露2026年半年度报告,8月20日股价上涨2.8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2660381942","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660381942?lang=zh_cn&edition=full","pubTime":"2026-08-20 22:33","pubTimestamp":1787236395,"startTime":"0","endTime":"0","summary":"截至2026年8月20日收盘,润都股份报收于11.76元,较前一交易日上涨2.8%,最新总市值为39.38亿元。该股当日开盘11.72元,最高11.99元,最低11.58元,成交额达1.06亿元,换手率为3.48%。近日,润都股份披露《2026年半年度报告》。经营活动产生的现金流量净额为72,713,445.10元,同比增长669.59%。本报告期末总资产为2,024,884,765.92元,较上年度末减少0.18%;归属于上市公司股东的净资产为1,079,148,093.98元,较上年度末增长3.92%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082000045624.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002923"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659161891","title":"股市必读:润都股份(002923)股东户数2.29万户,较上期增加9.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2659161891","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659161891?lang=zh_cn&edition=full","pubTime":"2026-08-14 01:48","pubTimestamp":1786643297,"startTime":"0","endTime":"0","summary":"截至2026年8月13日收盘,润都股份报收于11.66元,上涨0.52%,换手率4.24%,成交量10.94万手,成交额1.28亿元。股本股东变化:截至2026年8月10日,润都股份股东户数为2.29万户,较7月31日增长9.49%。股本股东变化股东户数变动截至2026年8月10日,润都股份股东户数为2.29万户,较7月31日增加1981.0户,增幅9.49%;户均持股数量由1.6万股减少至1.46万股,户均持股市值16.83万元。投资者: 10日盘后股东人数董秘: 尊敬的投资者,您好!","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081400001179.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002923","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659913457","title":"润都股份:截至2026年08月10日,公司总户数为22,860户","url":"https://stock-news.laohu8.com/highlight/detail?id=2659913457","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659913457?lang=zh_cn&edition=full","pubTime":"2026-08-13 15:42","pubTimestamp":1786606929,"startTime":"0","endTime":"0","summary":"证券之星消息,润都股份(002923)08月13日在投资者关系平台上答复投资者关心的问题。投资者提问:截至8.11日,公司股东人数?润都股份回复:尊敬的投资者,您好!截至2026年08月10日,公司总户数为22,860户。感谢您的关注!本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。责任编辑:陈思雨","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081300021029.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002923"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657172425","title":"8月5日润都股份发生5笔大宗交易 成交金额1462.92万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2657172425","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657172425?lang=zh_cn&edition=full","pubTime":"2026-08-05 17:41","pubTimestamp":1785922861,"startTime":"0","endTime":"0","summary":"证券之星消息,8月5日润都股份发生大宗交易,交易数据如下:近三个月该股共发生17笔大宗交易,合计成交5.82万手,折价成交17笔。该股近期无解禁股上市。截至2026年8月5日收盘,润都股份(002923)报收于10.89元,上涨0.09%,换手率3.73%,成交量9.62万手,成交额1.05亿元。该股近半年内有股东持股变动,合计净减持1481.62万股,股东增减持明细如下表:该股最近90天内无机构评级。本文数据来源于深圳证券交易所大宗交易信息披露,仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080500032203.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002923"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656312455","title":"润都股份(002923)7月31日股东户数2.09万户,较上期减少9.89%","url":"https://stock-news.laohu8.com/highlight/detail?id=2656312455","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656312455?lang=zh_cn&edition=full","pubTime":"2026-08-04 17:50","pubTimestamp":1785837040,"startTime":"0","endTime":"0","summary":"证券之星消息,近日润都股份披露,截至2026年7月31日公司股东户数为2.09万户,较7月20日减少2292.0户,减幅为9.89%。在化学制药行业个股中,润都股份股东户数低于行业平均水平,截至7月31日,化学制药行业平均股东户数为3.6万户。从股价来看,2026年7月20日至2026年7月31日,润都股份区间跌幅为2.17%,在此期间股东户数减少2292.0户,减幅为9.89%。以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080400030005.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002923"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656354135","title":"润都股份:截至2026年07月31日,公司总户数为20,879户","url":"https://stock-news.laohu8.com/highlight/detail?id=2656354135","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656354135?lang=zh_cn&edition=full","pubTime":"2026-08-04 16:18","pubTimestamp":1785831488,"startTime":"0","endTime":"0","summary":"证券之星消息,润都股份(002923)08月04日在投资者关系平台上答复投资者关心的问题。投资者提问:截至8.1日,公司股东人数?润都股份回复:尊敬的投资者,您好!截至2026年07月31日,公司总户数为20,879户。感谢您的关注!本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。责任编辑:刘浩然","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080400026332.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002923"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655882880","title":"股市必读:7月28日润都股份发生2笔大宗交易 成交金额966万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2655882880","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2655882880?lang=zh_cn&edition=full","pubTime":"2026-07-29 02:49","pubTimestamp":1785264550,"startTime":"0","endTime":"0","summary":"截至2026年7月28日收盘,润都股份报收于10.58元,下跌1.4%,换手率2.64%,成交量6.82万手,成交额7270.6万元。大宗交易7月28日润都股份发生2笔大宗交易,成交金额966万元。本次担保在公司2026年度为子公司预计提供的20,000万元担保额度内。截至公告日,公司对合并报表范围内子公司的担保余额为32,359.09万元,占2025年度经审计净资产的31.16%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072900001713.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002923"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654016643","title":"润都股份(002923)7月20日股东户数2.32万户,较上期增加13.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2654016643","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2654016643?lang=zh_cn&edition=full","pubTime":"2026-07-27 17:35","pubTimestamp":1785144952,"startTime":"0","endTime":"0","summary":"证券之星消息,近日润都股份披露,截至2026年7月20日公司股东户数为2.32万户,较7月10日增加2673.0户,增幅为13.04%。在化学制药行业个股中,润都股份股东户数低于行业平均水平,截至7月20日,化学制药行业平均股东户数为3.58万户。从股价来看,2026年7月10日至2026年7月20日,润都股份区间跌幅为0.84%,在此期间股东户数增加2673.0户,增幅为13.04%。以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072700022886.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002923"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654509074","title":"润都股份:截至2026年07月20日,公司总户数为23,171户","url":"https://stock-news.laohu8.com/highlight/detail?id=2654509074","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2654509074?lang=zh_cn&edition=full","pubTime":"2026-07-27 15:51","pubTimestamp":1785138667,"startTime":"0","endTime":"0","summary":"证券之星消息,润都股份(002923)07月27日在投资者关系平台上答复投资者关心的问题。投资者提问:截至2026.07.21,股东人数?润都股份回复:尊敬的投资者,您好!截至2026年07月20日,公司总户数为23,171户。感谢您的关注!本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。责任编辑:陈思雨","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072700016288.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002923","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653710727","title":"润都股份(002923.SZ):硝酸异山梨酯注射液获得药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2653710727","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653710727?lang=zh_cn&edition=full","pubTime":"2026-07-23 16:47","pubTimestamp":1784796439,"startTime":"0","endTime":"0","summary":"智通财经APP讯,润都股份(002923.SZ)发布公告,公司近日收到国家药品监督管理局签发的硝酸异山梨酯注射液(规格5ml:5mg)《药品注册证书》。该药品适用于与标准治疗联合用于不稳定性心绞痛的对症治疗,血管痉挛性心绞痛(变异型心绞痛)的长期治疗;急性心肌梗死;急性左心衰竭(伴有左心室功能降低的心力衰竭)。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1471405.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"润都股份(002923.SZ):硝酸异山梨酯注射液获得药品注册证书","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","002923"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653220596","title":"润都股份(002923)披露获得碳酸镧化学原料药上市申请批准通知书,7月21日股价下跌1.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2653220596","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653220596?lang=zh_cn&edition=full","pubTime":"2026-07-21 22:23","pubTimestamp":1784643795,"startTime":"0","endTime":"0","summary":"截至2026年7月21日收盘,润都股份报收于10.42元,较前一交易日下跌1.51%,最新总市值为34.9亿元。该股当日开盘10.6元,最高10.63元,最低10.0元,成交额达1.62亿元,换手率为6.13%。近日,珠海润都制药股份有限公司收到国家药品监督管理局签发的碳酸镧化学原料药上市申请批准通知书,原料药名称为碳酸镧,申请人为珠海润都制药股份有限公司,审批结论为符合药品注册有关要求,批准注册。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072100044750.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002923","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653202072","title":"润都股份(002923.SZ)获得碳酸镧化学原料药上市申请批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2653202072","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653202072?lang=zh_cn&edition=full","pubTime":"2026-07-21 16:50","pubTimestamp":1784623814,"startTime":"0","endTime":"0","summary":"智通财经APP讯,润都股份(002923.SZ)发布公告,公司近日收到国家药品监督管理局签发的关于碳酸镧《化学原料药上市申请批准通知书》。碳酸镧咀嚼片用于血液透析或持续非卧床腹膜透析的慢性肾功能衰竭患者高磷血症的治疗。本次获碳酸镧原料药上市申请批准通知书,扩充了公司在慢病治疗领域的产品矩阵,符合公司发展战略。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1470345.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","IPOS","002923"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652426923","title":"股市必读:润都股份(002923)股东户数1.86万户,较上期减少3.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2652426923","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652426923?lang=zh_cn&edition=full","pubTime":"2026-07-17 01:24","pubTimestamp":1784222652,"startTime":"0","endTime":"0","summary":"截至2026年7月16日收盘,润都股份报收于11.83元,上涨0.17%,换手率10.74%,成交量27.72万手,成交额3.26亿元。股本股东变化股东户数变动截至2026年6月30日公司股东户数为1.86万户,较6月18日减少665.0户,减幅为3.46%。户均持股数量由上期的1.74万股增加至1.8万股,户均持股市值为17.06万元。截至2026年06月30日,公司总户数为18,568户。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071700000783.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002923"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651417166","title":"润都股份:公司二季度业绩增长的主要原因为销售量增加及产能提升","url":"https://stock-news.laohu8.com/highlight/detail?id=2651417166","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651417166?lang=zh_cn&edition=full","pubTime":"2026-07-16 16:42","pubTimestamp":1784191327,"startTime":"0","endTime":"0","summary":"公司全球首创1类新药盐酸去甲乌药碱注射液于2026年4月取得药品注册证书后,二季度主要开展上市筹备、经销商准入、学术推广、医保谈判前期准备等商业化落地工作,该产品短期内不会对业绩产生重大影响。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071600026743.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002923","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651341228","title":"润都股份:截至2026年06月30日,公司总户数为18,568户","url":"https://stock-news.laohu8.com/highlight/detail?id=2651341228","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651341228?lang=zh_cn&edition=full","pubTime":"2026-07-16 16:21","pubTimestamp":1784190069,"startTime":"0","endTime":"0","summary":"证券之星消息,润都股份(002923)07月16日在投资者关系平台上答复投资者关心的问题。投资者提问:董秘您好!请问截止到2026年7月1日的股东人数是多少?润都股份回复:尊敬的投资者,您好!截至2026年06月30日,公司总户数为18,568户。感谢您的关注!本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。责任编辑:刘浩然","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071600026083.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002923"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651658104","title":"润都股份(002923)披露盐酸去甲乌药碱注射液入选广东省创新药械产品目录(第三批),7月14日股价下跌2.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2651658104","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651658104?lang=zh_cn&edition=full","pubTime":"2026-07-14 22:23","pubTimestamp":1784038994,"startTime":"0","endTime":"0","summary":"截至2026年7月14日收盘,润都股份报收于11.04元,较前一交易日下跌2.13%,最新总市值为36.97亿元。该股当日开盘11.15元,最高11.37元,最低10.69元,成交额达2.51亿元,换手率为8.88%。近日,珠海润都制药股份有限公司发布公告称,其盐酸去甲乌药碱注射液入选广东省已获批创新药械产品目录(第三批)。根据政策,入选产品将享受广东省促进创新药械发展的支持政策,有利于公司在广东省内的临床推广和市场销售。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071400049639.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","399265","002923"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651190208","title":"润都股份(002923)披露2026年半年度业绩预告,XX月XX日股价上涨5.72%","url":"https://stock-news.laohu8.com/highlight/detail?id=2651190208","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651190208?lang=zh_cn&edition=full","pubTime":"2026-07-13 17:46","pubTimestamp":1783936015,"startTime":"0","endTime":"0","summary":"截至2026年7月13日收盘,润都股份报收于11.28元,较前一交易日上涨5.72%,最新总市值为37.78亿元。该股当日开盘10.7元,最高11.44元,最低10.6元,成交额达2.79亿元,换手率为9.85%。近日,润都股份披露《2026年半年度业绩预告》。本期业绩预告数据未经会计师事务所审计,最终数据以2026年半年度报告为准。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071300026644.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002923"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650632431","title":"润都股份预计上半年净利同比增长196.7%至216.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2650632431","media":"北京商报","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2650632431?lang=zh_cn&edition=full","pubTime":"2026-07-12 20:46","pubTimestamp":1783860360,"startTime":"0","endTime":"0","summary":"北京商报讯 7月12日晚间,润都股份发布2026年半年度业绩预告显示,公司预计2026年上半年实现归属净利润3500万元至4200万元,同比增长196.7%至216.04%。润都股份表示,报告期内,公司积极把握市场机遇,大力开拓国内外销售市场,原料药、制剂产品销售量有所增加;另子公司荆门公司产能利用率稳步提升,生产规模持续扩大,推动产品成本下降,共同带动公司原料药与制剂产品销售收入、毛利实现较大幅度增长。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2026-07-12/doc-inihqetv4488966.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-07-12/doc-inihqetv4488966.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0239","002923"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1787418967010,"stockEarnings":[{"period":"1week","weight":-0.0284},{"period":"1month","weight":0.0899},{"period":"3month","weight":-0.0384},{"period":"6month","weight":-0.2774},{"period":"1year","weight":-0.2311},{"period":"ytd","weight":-0.0716}],"compareEarnings":[{"period":"1week","weight":-0.0056},{"period":"1month","weight":0.0099},{"period":"3month","weight":-0.0505},{"period":"6month","weight":-0.0433},{"period":"1year","weight":0.0356},{"period":"ytd","weight":-0.016}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"珠海润都制药股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"22860人(较上一季度增加9.49%)","perCapita":"11288股","listingDate":"2018-01-05","address":"广东省珠海市金湾区三灶镇机场北路6号","registeredCapital":"33489万元","survey":" 珠海润都制药股份有限公司的主营业务是化学药制剂、化学原料药、中间体的研发、生产和销售。公司的主要产品是化学药制剂、化学原料药、中间体。公司是国家高新技术企业,国家绿色工厂、国家知识产权优势企业,研发中心先后被认定为国家级博士后科研工作站、国家企业技术中心、广东省企业技术中心、广东省缓控释微丸胶囊制剂工程研究中心,承担了国家重大新药创制专项、国家火炬计划、国家高新技术产业化项目等科研课题。","listedPrice":17.01},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"润都股份(002923)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供润都股份(002923)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"润都股份,002923,润都股份股票,润都股份股票老虎,润都股份股票老虎国际,润都股份行情,润都股份股票行情,润都股份股价,润都股份股市,润都股份股票价格,润都股份股票交易,润都股份股票购买,润都股份股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"润都股份(002923)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供润都股份(002923)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}